Cargando…

Tyrosine Kinase Inhibitor Pazopanib Inhibits Platelet Procoagulant Activity in Renal Cell Carcinoma Patients

Pazopanib is an angiostatic tyrosine kinase inhibitor (TKI) presently used for cancer treatment, particularly in patients with renal cell carcinoma (RCC). This treatment can be accompanied by mild bleeding as an adverse effect. Given the role of protein tyrosine kinases in platelet activation proces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tullemans, Bibian M. E., Nagy, Magdolna, Sabrkhany, Siamack, Griffioen, Arjan W., oude Egbrink, Mirjam G. A., Aarts, Maureen, Heemskerk, Johan W. M., Kuijpers, Marijke J. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6232667/ https://www.ncbi.nlm.nih.gov/pubmed/30460241 http://dx.doi.org/10.3389/fcvm.2018.00142

Ejemplares similares

Platelets as messengers of early-stage cancer
por: Sabrkhany, Siamack, et al.
Publicado: (2021)

Age- and gender-matched controls needed for platelet-based biomarker studies
por: Sabrkhany, Siamack, et al.
Publicado: (2022)

Multiparameter Evaluation of the Platelet-Inhibitory Effects of Tyrosine Kinase Inhibitors Used for Cancer Treatment
por: Tullemans, Bibian M. E., et al.
Publicado: (2021)

Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study
por: Tullemans, Bibian M. E., et al.
Publicado: (2022)

The Analysis of Platelet-Derived circRNA Repertoire as Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer
por: D’Ambrosi, Silvia, et al.
Publicado: (2021)

Effects of Cancer Presence and Therapy on the Platelet Proteome
por: Walraven, Maudy, et al.
Publicado: (2021)

Galectin-1 and platelet factor 4 (CXCL4) induce complementary platelet responses in vitro
por: Dickhout, Annemiek, et al.
Publicado: (2021)

Tumor-educated platelet blood tests for Non-Small Cell Lung Cancer detection and management
por: Antunes-Ferreira, Mafalda, et al.
Publicado: (2023)

Effects of Platelet Agonists and Priming on the Formation of Platelet Populations
por: Veninga, Alicia, et al.
Publicado: (2021)

Ultra-high-throughput Ca(2+) assay in platelets to distinguish ITAM-linked and G-protein-coupled receptor activation
por: Fernández, Delia I., et al.
Publicado: (2021)

Stabilizing Role of Platelet P2Y(12) Receptors in Shear-Dependent Thrombus Formation on Ruptured Plaques
por: Nergiz-Unal, Reyhan, et al.
Publicado: (2010)

Protein C or Protein S deficiency associates with paradoxically impaired platelet‐dependent thrombus and fibrin formation under flow
por: Brouns, Sanne L. N., et al.
Publicado: (2022)

Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome
por: van Geffen, Johanna P., et al.
Publicado: (2020)

Effect of antiplatelet agents and tyrosine kinase inhibitors on oxLDL-mediated procoagulant platelet activity
por: Zheng, Tony J., et al.
Publicado: (2022)

The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib
por: Wilding, Christopher P, et al.
Publicado: (2019)

Cross-resistance to clinically used tyrosine kinase inhibitors sunitinib, sorafenib and pazopanib
por: Gotink, Kristy J., et al.
Publicado: (2015)

Platelet GPVI (Glycoprotein VI) and Thrombotic Complications in the Venous System
por: Perrella, Gina, et al.
Publicado: (2021)

Comparison of inhibitory effects of irreversible and reversible Btk inhibitors on platelet function
por: Tullemans, Bibian M.E., et al.
Publicado: (2021)

Gray Hair Associated with the Multitargeted Receptor Tyrosine Kinase Inhibitor Pazopanib
por: Yun, Hwan-Jung, et al.
Publicado: (2015)

Improved Glycemic Control With the Multi-Receptor Tyrosine Kinase Inhibitor Pazopanib
por: Böhm, Steffen, et al.
Publicado: (2010)

Temporal Roles of Platelet and Coagulation Pathways in Collagen- and Tissue Factor-Induced Thrombus Formation
por: Navarro, Stefano, et al.
Publicado: (2021)

Role of Platelet Glycoprotein VI and Tyrosine Kinase Syk in Thrombus Formation on Collagen-Like Surfaces
por: Jooss, Natalie J., et al.
Publicado: (2019)

Molecular Mechanisms of Hemostasis, Thrombosis and Thrombo-Inflammation
por: Kuijpers, Marijke J. E., et al.
Publicado: (2022)

Increasing value in research: cost evaluations in health professions education
por: Schreurs, Sanne, et al.
Publicado: (2019)

Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
por: Vasudev, Naveen S., et al.
Publicado: (2011)

Small-Molecule Cyclophilin Inhibitors Potently Reduce Platelet Procoagulant Activity
por: Van Bael, Jens, et al.
Publicado: (2023)

GPVI expression is linked to platelet size, age, and reactivity
por: Veninga, Alicia, et al.
Publicado: (2022)

Procoagulant Phosphatidylserine-Exposing Platelets in vitro and in vivo
por: Reddy, Emily C., et al.
Publicado: (2020)

Procoagulant platelets: Generation, characteristics, and therapeutic target
por: Chu, Yaxin, et al.
Publicado: (2021)

Analysis of procoagulant phosphatidylserine‐exposing platelets by imaging flow cytometry
por: Reddy, Emily C., et al.
Publicado: (2018)

Chloride channels are necessary for full platelet phosphatidylserine exposure and procoagulant activity
por: Harper, M T, et al.
Publicado: (2013)

Procoagulant inhibitory properties of paclitaxel poliglumex
por: Nemunaitis, John, et al.
Publicado: (2010)

The value of quantitative patient preferences in regulatory benefit-risk assessment
por: Egbrink, Mart oude, et al.
Publicado: (2014)

Characterization of Procoagulant COAT Platelets in Patients with Glanzmann Thrombasthenia
por: Aliotta, Alessandro, et al.
Publicado: (2020)

Cytosolic and mitochondrial Ca(2+) signaling in procoagulant platelets
por: Millington-Burgess, Sarah L., et al.
Publicado: (2021)

Another piece of knowledge in the puzzle of procoagulant COAT platelets
por: Aliotta, Alessandro, et al.
Publicado: (2022)

Preeclampsia: Platelet procoagulant membrane dynamics and critical biomarkers
por: Agbani, Ejaife O., et al.
Publicado: (2023)

Dose-Dependent Effects of Oral Tyrosine Administration on Plasma Tyrosine Levels and Cognition in Aging
por: van de Rest, Ondine, et al.
Publicado: (2017)

Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets
por: Zhang, Pengyu, et al.
Publicado: (2023)

Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?
por: Agbani, Ejaife O., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7tinttt42aphaptg38sbglgv5i